T65.21
Toxic effect of chewing tobacco
Clinical Classification Guidelines
Medical Intelligence & Overview
Chewing tobacco is a form of smokeless tobacco that is placed in the mouth, between the gum and cheek or lip. While commonly used by some individuals, it contains nicotine and other harmful chemicals that can lead to toxic effects in the body. Recognizing the potential health risks associated with chewing tobacco is important for informed decision-making and health management. The ICD-10 code T65.21 specifically indicates a toxic effect caused by chewing tobacco, highlighting the impact of such products on health.
Causes & Symptoms
Clinical Causes: Use of chewing tobacco containing nicotine and other harmful chemicals. Prolonged exposure to toxic substances present in the tobacco product. Accidental ingestion or swallowing of larger amounts of chewing tobacco substances. Repeated contact with carcinogenic compounds found in tobacco products. Increased susceptibility to poisoning when used in combination with alcohol or other substances.
Key Symptoms: Nausea and vomiting, especially after initial use or excessive consumption. Dizziness or lightheadedness, potentially indicating nicotine poisoning. Increased salivation or salivary gland swelling. Oral discomfort, including mouth ulcers or irritation. Headache and blurred vision in some cases. Rapid heartbeat or irregular heart rhythm. Elevated blood pressure. Weakness or dizziness upon standing. Respiratory issues such as coughing or difficulty breathing in severe cases. General signs of toxicity like confusion or tremors.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of a toxic effect due to chewing tobacco involves a comprehensive evaluation by a healthcare professional, including a review of recent usage history. Physical examination may reveal signs related to oral and systemic toxicity. Laboratory tests, such as blood and urine analyses, can detect the presence of nicotine and other toxins. Additional tests might include ECG to assess heart function and other relevant investigations based on symptoms. Accurate diagnosis assists in identifying the extent of exposure and guiding appropriate management.
Treatment Protocols: Management of toxic effects from chewing tobacco includes supportive care and addressing symptoms. Immediate steps may involve removing the tobacco from the oral cavity and providing anti-nausea or anti-diarrheal medications if needed. In cases of severe poisoning, hospitalization can be required for close monitoring, administration of activated charcoal, intravenous fluids, and medications to stabilize vital signs. Long-term strategies focus on cessation support, including counseling and behavioral therapies, to help individuals quit chewing tobacco and reduce health risks. Health professionals may also recommend regular monitoring for potential complications like cardiovascular or oral health issues.
Clinical Advice & FAQs
Billing Guidance
Is T65.21 a billable ICD-10 code?
Yes, T65.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T65.21?
Clinical documentation must specify the nature of Toxic effect of chewing tobacco and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
